Biomm (BSP:BIOM3) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 05, 2026)


BSP:BIOM3 Biomm SA BSP:BIOM3
51 GF Score
Price R$6.20
GF Value R$15.91
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Biomm Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Biomm's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


BSP:BIOM3 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Biomm's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomm Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomm's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Biomm's Margin of Safety % (DCF Earnings Based) falls into.


BSP:BIOM3
51GF Score
Biomm SA BSP:BIOM3
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biomm (BSP:BIOM3) Overvalued in 2026?

Based on GuruFocus' analysis, Biomm stock appears to be undervalued. The current stock price of R$6.20 is trading 61% below its estimated GF Value™ of R$15.91. GuruFocus considers Biomm to be Possible Value Trap.

Key valuation signals for BSP:BIOM3:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: R$15.91 vs. price of R$6.20 (61% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the BSP:BIOM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biomm Business Description

Address Praca Carlos Chagas 49 - 8th Floor, Belo Horizonte, Minas Gerais, MG, BRA, 30170020
Biomm SA is engaged in biotechnological processes for the production of active pharmaceutical ingredients and other industrial purposes, such as enzymes used in the production of Biofuels.The Company is patented for insulin production.The company develops processes for the production of insulin and other biotech products, as well as processes for other industrial applications, such as enzymes that are used in the production of biofuels.
51GF Score

Get the complete analysis for BSP:BIOM3

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.20
Price
R$15.91
GF Value